Journal of Intellectual Property Rights

Open Access Open Access  Restricted Access Subscription Access

A Paradigm Shift in Indian and International Patent Regime- Critical Review on Ex- and Current Scenario (Covid-19 Impact)


Affiliations
1 KLEF College of Law, KLEF (Deemed to be) University, Greenfields, Vaddeswaram — 522 302, Guntur Dist, AP, India
 

The innovation markers are namely patents which give the creation the identity, novelty and utilization in industry or for commercial use in public. There were many patents filed under different judicatory laws of different countries which give the sole right and responsibility to own the invention till the expiry of patent by the owner (Patentee). The rules and regulations also enable the patentee to take necessary action against the misuse or prior use and also copying of invention. There are circumstances like national emergency like the Covid -19 pandemic which could create the urgency to make public access for the medicines under the clinical trial or the generic form before the expiry of the patent in order to increase the health care needs. The national emergency globally has awaken to recreate or amend few judiciary laws of different countries like waiver of patents, compulsory licenses and also paying a remuneration amount to the patentee. The countries like U.S, India, China, Japan have played a key role in managing the pandemic by encouraging generic medicine manufacturing and licensing. The COVID-19 crisis affects not only Patent Law. However, COVID-19 clearly presents an imminent threat to public health which, in most jurisdictions, is likely to justify the grant of compulsory licenses and more changes in the few penal codes and articles under specific provisions made by the government. There was also huge impact on the patent filings by different countries which enumerated the increase of 16 % by China and also a significant contribution by the countries like U.S, India, Europe, Japan, Italy, etc. The Data exclusivity was reported including the women investors share which is considerably high. The pandemic has shaped new reforms in digitalization aspects and kept open many avenues in the medical and technology sectors in the years to come.

Keywords

Patent, Covid-19, Reforms, Impact on Patent Rights, Digitalization.
User
Notifications
Font Size

  • World Economic Outlook Reports.

  • WHO-COVID-19 Weekly Epidemiological Update, 15 June 2021.

  • www.internationallawoffice.com

  • Philip S & Sourrouille D M, COVID-19 mortality in rich and poor countries: A tale of two pandemics? (English), Policy Research working Paper No. WPS 9260; COVID-19 (Coronavirus) Washington, D.C.: World Bank Group 2020.

  • Commercialising a pandemic – how to balance patents and public health emergencies.

  • Wilson N, Anand & Anand, India: Go digital and be simple in 2020 with new Patent Rules in India, 10 March 2021.

  • USPTO notices regarding Covid-19, www.uspto.gov/coronavirus, last accessed 13 May 2020.

  • Notice of Waiver of Patent-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act, www.uspto.gov/sites/default/files/documents/Patents-Notice-CARES-Act-2020-03.pdf (accessed on 13 May 2020).

  • Notice of Waiver of Trademark-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act, www.uspto.gov/sites/default/files/documents/TM-Notice-CARES-Act.pdf (accessed on 13 May 2020).

  • Notice of Extended Waiver of Patent-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act and Other Relief Available to Patent Applicants and Patentees, www.uspto.gov/sites/default/files/documents/ Patents-.

  • Notice-CARES-Act-2020-04.pdf, (accessed on 13 May 2020); Notice of Extended Waiver of Trademark-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act and Other Relief Available to Trademark Applicants and Trademark Owners, www.uspto.gov/sites/default/files/documents/TM-Notice-CARES-Act-2020-04.pdf (accessed on 13 May 2020).

  • Relief Available to Patent and Trademark Applicants, Patentees and Trademark Owners Affected by the Coronavirus Outbreak, www.uspto.gov/sites/default/files/documents/coronavirus_relief_ognotice_03162020.pdf (accessed on 13 May 2020).

  • Notice of Extended Waiver of Patent-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act and Other Relief Available to Patent Applicants and Patentees; Notice of Extended Waiver of Trademark-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act and Other Relief Available to Trademark.

  • WIPO statistics database.

  • Patents and Patent Trial and Appeal Board (PTAB) FAQs: Extension of Deadlines under the CARES Act, available at www.uspto.gov/patent/laws-and-regulations/cares-act-faqs, last accessed 14 May 2020; Trademarks and Trademark Trial and Appeal Board (TTAB) FAQs: Extension of Deadlines under the CARES Act, available at www.uspto.gov/ trademark/ laws-regulations/cares-act-faqs, (accessed on 14 May 2020).

  • Sharma S, India, Covid-19: Patent, Economy, Prophylaxis and Treatment, 25 June 2020.

  • Ganju R, India's Regulatory Response To COVID 19 – Support For Vaccine Development And Distribution, Phoenix Legal, 5 October 2020.

  • Karavida N, Onofrio D & Merlen D, Patent rights and wrongs in the COVID-19 pandemic: EU and US approaches to compulsory licensing, 19 May 2020.

  • WIPO Director General Francis Gurry at the press launch of the World Intellectual Property Indicators report, World Intellectual Property Indicators: Filings for Patents, Trademarks, Industrial Designs Reach Record Heights in 2018, Geneva, 16 October 2019.

  • Global patents applications: India puts up a poor show, even Huawei has more filings, Financial Express, Banikinkar Pattanayak, 24 August 2020.

  • Szmigiera M, Countries that filed the most international patent applications 2020, 5 May 2021.

  • COVID-19 Prioritized Examination Pilot Program, www.uspto.gov/initiatives/covid-19-prioritized-examination-pilot (accessed on 13 May 2020).

  • OECD, 2021, Economic Outlook, (2) (2020) 108, OECD Publishing, Paris. 20 Eurostat, 2021, Production in industry - monthly data, Online data code: STS_INPR_M, https://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=sts_inpr_m〈=en.

  • OECD, 2021, Economic Outlook, (2) (2020) 108, OECD Publishing, Paris. 22.

  • World Bank, 2021, Global Economic Prospects, https://www.worldbank.org/en/publication/global-economic-prospects. 23 Ibid.

  • Accenture, 2020, Coronavirs automotive rapid response, https://www.accenture.com/us-en/insights/automotive/coronaviru sautomotive-rapid-response.

  • China: China files more European patent applications despite pandemic, April 2021 by AFD China Intellectual Property (Beijing) AFD China.

  • Walsh K, Wallace A, Pavis M et al., Intellectual property rights and access in crisis, IIC, 52 379–416 (2021), https://doi.org/10.1007/s40319-021-01041-1.

  • WIPO Statistical center, International IP Applications: Current Status in the World and Japan, 26 May 2020.

  • Trevisan & Cuonzo, EPO released the Patent Index 2020: In the year of Covid-19, Italy plays a major role in healthcare innovation, European Union, Italy, 12 April 2021.

  • Global overview: Compulsory licensing and new provisions, During the State of Health Emergency Administrative Supreme Court (Conseil d'État), Summary proceedings, Collegial formation, 26 July 2018, No. 422237.

  • Szmigiera M, Intellectual property worldwide - Statistics & Facts, 1 July 2021.

  • Michael K H, Where should we file in 2020? Recent Trends in Foreign Patent Filings, 22 November 2019.

  • Innovation perseveres: International Patent Filings via WIPO continued to grow in 2020 despite COVID-19 pandemic.


Abstract Views: 105

PDF Views: 81




  • A Paradigm Shift in Indian and International Patent Regime- Critical Review on Ex- and Current Scenario (Covid-19 Impact)

Abstract Views: 105  |  PDF Views: 81

Authors

Kadiyala Venkata Sahitya
KLEF College of Law, KLEF (Deemed to be) University, Greenfields, Vaddeswaram — 522 302, Guntur Dist, AP, India
K I Pavan Kumar
KLEF College of Law, KLEF (Deemed to be) University, Greenfields, Vaddeswaram — 522 302, Guntur Dist, AP, India

Abstract


The innovation markers are namely patents which give the creation the identity, novelty and utilization in industry or for commercial use in public. There were many patents filed under different judicatory laws of different countries which give the sole right and responsibility to own the invention till the expiry of patent by the owner (Patentee). The rules and regulations also enable the patentee to take necessary action against the misuse or prior use and also copying of invention. There are circumstances like national emergency like the Covid -19 pandemic which could create the urgency to make public access for the medicines under the clinical trial or the generic form before the expiry of the patent in order to increase the health care needs. The national emergency globally has awaken to recreate or amend few judiciary laws of different countries like waiver of patents, compulsory licenses and also paying a remuneration amount to the patentee. The countries like U.S, India, China, Japan have played a key role in managing the pandemic by encouraging generic medicine manufacturing and licensing. The COVID-19 crisis affects not only Patent Law. However, COVID-19 clearly presents an imminent threat to public health which, in most jurisdictions, is likely to justify the grant of compulsory licenses and more changes in the few penal codes and articles under specific provisions made by the government. There was also huge impact on the patent filings by different countries which enumerated the increase of 16 % by China and also a significant contribution by the countries like U.S, India, Europe, Japan, Italy, etc. The Data exclusivity was reported including the women investors share which is considerably high. The pandemic has shaped new reforms in digitalization aspects and kept open many avenues in the medical and technology sectors in the years to come.

Keywords


Patent, Covid-19, Reforms, Impact on Patent Rights, Digitalization.

References